Immunocompromised Get Effective But Less Protection from 2 mRNA COVID Vaccines, Notes New COVID VISION Project Research

Two doses of mRNA COVID-19 vaccines have been found to be effective in preventing laboratory-confirmed COVID-19 hospitalizations among patients who were immunocompromised (77%) and those who were immunocompetent (90%). Nonetheless, immunocompromised patients were less protected from severe COVID-19 compared with immunocompetent patients, and vaccine effectiveness varied considerably among immunocompromised patient subgroups, ranging from 59% among organ or stem cell transplant patients to 81% among patients with a rheumatologic or inflammatory disorder.

These findings support the recommendation that immunocompromised persons receiving mRNA COVID-19 vaccines should receive a 3rd dose and a booster, practice non-pharmaceutical interventions such as masking to prevent SARS-CoV-2 infection, and, if infected, be monitored closely and considered early for proven therapies that can prevent severe outcomes.

The new findings, Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January — September 2021, have been published in the Centers for Disease Control and Prevention’s (CDC’s) Morbidity and Mortality Weekly Report (MMWR).

The research was sponsored by CDC’s COVID VISION Project, which integrates medical, laboratory, pharmacy, and vaccination records to examine incidence, care trajectories, and outcomes associated with COVID-19 illness. Westat supports the clinical sites in this work. Our researchers were among the report’s coauthors: Matthew E. Levy, Ph.D.; Margaret M. Dunne, M.Sc.; Duck-Hye Yang, Ph.D.; Elizabeth A. Rowley, Dr.P.H.; Sarah W. Ball, Sc.D.; Patrick K. Mitchell, Sc.D.; Salome A. Kiduko, M.P.H.; Yan Zhuang, Ph.D.; Sarah E. Reese, Ph.D.

 

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Leadership Montgomery
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
SiriusXM
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
Toyota
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Maryland Baltimore Campus
University of Michigan
University System of Maryland
Explore Our Clients

Please wait...

Forbes 2021 The Best Employers for Women Powered by StatistaForbes 2021 The Best Employers for Diversity Powered by StatistaForbes 2021: America's Best Midsize Employer Powered by Statista Forbes 2021 The Best Employers for Veterans Powered by Statista

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.